Intelligent Bio Solutions starts interference study for FDA drug screening submission

Go back to Intelligent Bio Solutions starts interference study for FDA drug screening submission
(NASDAQ: INBS) Delayed: 2.51 -0.14 (5.28%)
Previous Close $2.65    52 Week High
Open $2.66    52 Week Low
Day High $2.70    P/E N/A 
Day Low $2.42    EPS
Volume 48,648